Session 5: Diabetes Flashcards

1
Q

What stimulates insulin secretion?

A

Increase in glucose

Incretins like GLP-1 and GIP

Glucagon

Parasympathetic activity via M3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is insulin inhibited by?

A

Decrease in glucose

Cortisol

Sympathetic activity (alpha 2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Role of insulin

A

Reduce hepatic glucose output via inhibition of gluconeogenesis

Inhibits glycogenolysis

Promotes uptake of fats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnostic criteria of diabetes.

A

Hyperglycaemia with a random plasma glucose >11 mmol/l

Some symptoms such as polyuria, polydipsia, weight loss, fatigue/lethargy.

Single raised plasma glucose without symptoms is not sufficient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors of type 2 diabetes.

A

Obesity

FH

Ethnicity

Diet

Drugs like thiazides, glucocorticoids and b-blockers

Low birth weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ways to investigate diabetes.

A

Glucose levels in blood

HbA1c levels (glycated haemoglobin) which reflects the average blood sugar over last 10-12 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is insulin made from?

A

Human insulin via recombinant DNA and reproduced via bacteria or yeast.

Or

Enzymatic modification of porcine insulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is insulin given and why?

A

Parenterally to avoid digestion in the gut.

This is because it is a protein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Routine administration of insulin.

A

Subcutaneous injection in upper arms, thighs, buttocks or/and abdomen.

IV is only given for emergencies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pharmacokinetics of insulin.

A

Half-life of 5 minutes in plasma and both renal and hepatic metabolism as well as elimination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When should insulin be given?

A

15-30 min prior to a meal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why might protamine and/or zinc be given in the same dose as insulin?

A

To modify absorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are insulin analogues and why might they be given?

A

A lab-grown modification of insulin to make it for example more rapidly acting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why is it important to rotate the site of administration of insulin?

A

Because given in the same spot can lead to lipodystrophy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are insulin aspart and insulin glargine?

A

Insulin analogues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is Ispophane/NPH insulin?

A

Insulin mixed with protamine and zinc.

This gives a slower acting insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Are combinations of insulin prescribed?

A

Yes.

Short and long acting mixtures of insulin can be prescribed and they may be taken separately.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How might insulin be administered? (what equipment)

A

By syringes, pens, pumps or inhalers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ADRs of insulin

A

Hypoglycaemia

Lipohypertrophy

Lipoatrophy

Also renal impairment leads to a higher risk of hypoglycaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When should you not take/be careful insulin?

A

When with steroids

Other hypoglycaemic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Give an example of a bolus dosing insulin.

A

Insulin Aspart which is rapid acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Give an example of a basal dosing insulin.

A

A long acting such as Insulin glargine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is diabetic ketoacidosis?

A

Hyperglycaemia

Acidosis

Ketonaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

When should you suspect DKA?

A

When blood glucose is above 11 mmol/l and there is:

an infection

Stress or trauma

Poor insulin adherence

ADRs

ketosis

Hyperglycaemi may not always be present and it can also present with low blood ketones.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Treatment of DKA

A

Prioritise fluids due to huge diuresis and then you give insulin.

You may also give glucose and K+ in order to not make them go hypoglycaemic or hypokalaemic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How is the insulin resistance usually overcome in T2DM?

A

By increased pancreatic insulin secretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What will the increase in pancreatic insulin secretion lead to?

A

Decrease in expression of insulin receptors and therefore less GLP-1 secretion in response to oral glucose as well.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How does beta-cell dysfunction happen in T2DM?

A

Glucotoxicity from fatty acids and ROS will cause beta-cell dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the initial treatments of T2DM?

A

Lifestyle modifications

Education

Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Why might adherence be low when been given insulin?

A

Due to perceived hypoglycaemia and perceived weight gain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

First line treatment of T2DM if HbA1c rises to 6.5% on lifestyle modifications.

A

Standard-release metformin

33
Q

What is given if standard-release metformin is not tolerated?

A

Modified release metformin

34
Q

If HbA1c still rises to 7.5% what is the next line of treatment?

A

Dual therapy with metformin and…:

DPP-4 inhibitors

Pioglitazone

An SU (gliclazide)

SGLT-2 inhibitor

35
Q

If dual therapy isn’t effective what is considered?

A

Tripe therapy of metformin, SU and…

DPP-4i

Pioglitazone

36
Q

Give an example of a biguanide.

A

Metformin

37
Q

Explain the mechanism of metformin.

A

Inhibition of gluconeogenesis and glycogenolysis

Also an increase in the glucose utilisation in skeletal muscle.

It also supress appetite

38
Q

Why might metformin have a better adherence than insulin?

A

Because it limits weight gain due to the suppression of appetite.

It is also taken in tablet form.

39
Q

ADRs of metformin.

A

Nausea

Vomiting

Diarrhoea

Lactic acidosis

40
Q

When should you be wary or not take metformin?

A

When eGFR is <30 ml/min

ACEi

Diuretics

NSAIDs

Any drugs really that can impair renal function.

Thiazide like diuretics

41
Q

Why might metformin not work well with thiazide like diuretics?

A

Because thiazide like diuretics can lead to increase in blood glucose and reduce metformin action.

42
Q

Mechanism of sulfonylureas.

A

Stimulate beta-cell pancreatic insulin secretion by blocking the ATP-dependant K+ channels. This leads to decrease in K+ conductance and membrane depolarisation.

The membrane depolarisation leads to an influx of Ca2+ and the Ca2+ binds to the insulin vesicle and insulin is released.

43
Q

What are sulfonylureas dependant on to work?

A

Residual pancreatic function.

If the beta-cells are destroyed then there is no insulin to be secreted.

44
Q

Why might adherence be worse with sulfonylureas than metformin?

A

Because of weight gain due to the anabolic effects of insulin

45
Q

When are sulfonylureas given?

A

In combination with other agents like dual or triple therapy or as a first line option if metformin is contraindicated.

46
Q

Give an example of a sulfonyurea.

A

Gliclazide

47
Q

ADRs of gliclazide.

A

Mild GI upset

Nausea, vomiting and diarrhoea

Hypoglycaemia

Some rare hypersensitivity reactions

48
Q

When should you not take gliclazide or be careful with it?

A

When taking other hypoglycaemic agents

Hepatic impairment

Renal impairment

Thiazide like diuretics leading to increased glucose.

49
Q

Explain the mechanism of Thiazolidinediones (glitazones)

A

Activation of PPAR-gamma. This leads increase insulin sensitivity where glucose is taken up by muscle and adipose tissue and that leads to reduced hepatic glucose output and lowered blood glucose.

50
Q

Why might adherence be worse with glitazones than with metformin?

A

Because glucose is turned into TAGs causing fat cell differentiation and weight gain.

51
Q

ADRs of glitazones.

A

GI upset

Fluid retention

Fracture risk

CVD concerns

Bladder cancer

52
Q

When should you be careful or wary of prescribing glitazones?

A

When the patient is on other hypoglycaemic agents

53
Q

Give examples of glitazones.

A

Pioglitazone

Rosiglitazone

54
Q

Explain mechanism of SGLT-2 inhibitors.

A

Less glucose absorption from tubular filtrate leading to increased urinary glucose excretion.

They are competitive reversible inhibitors of SGLT-2 in PCT.

55
Q

SGLT-2 inhibitors and weight.

A

Modest weight loss and a low risk of hypoglycaemia.

56
Q

When are SGLT-2is given?

A

Used in type 1 diabetes but with a risk of DKA.

Used for type 2 as add on therapy.

57
Q

ADRs of SGLT-2i

A

UTI

Genital infection

Thirst

Polyuria

58
Q

Contraindications of SGLT-2i

A

Antihypertensives

Hypoglycaemic

59
Q

Examples of SGLT-2i

A

Dapagliflozin

Canagliflozin

60
Q

Physiological effects of GLP-1 (an incretin)

Glucagon-like peptide

A
61
Q

Explain mechanism of DPP-4is

A

Prevent incretin degradation leading to increased plasma incretin levels.

The incretins glucose dependant so postprandial action.

62
Q

Why is the risk of hypoglycaemia low with DPP-4is?

A

Do not stimulate insulin secretion at normal blood glucose.

Incretins are dependant on glucose to stimulate the insulin secretion.

63
Q

DPP-4 inhibitors and weight.

A

Supress appetite meaning weight neutral.

64
Q

When are DPP-4is given?

A

Combination with other agents or a first line option if metformin is contraindicated.

65
Q

ADRs of DPP4i.

A

GI upset

Small pancreatitis risk

Avoid in pregnancy

66
Q

Contraindications of DPP-4i

A

Hypoglycaemic agents

Drugs that increase glucose blood can oppose the action such as thiazide like diuretics and loop diuretics.

67
Q

Give examples of DPP4-is.

A

Sitagliptin

Saxagliptin

68
Q

Explain mechanism of GLP-1 receptor agonists.

A

Glucose dependant synthesis of insulin secretion from Beta-cells activate GLP-1 receptor and are not degraded by DPP-4.

They are incretin mimetics.

69
Q

How are GLP-1 receptor agonists administered?

A

Subcutaneous injection

70
Q

GLP-1 receptor agonists and weight.

A

Promote satiety

71
Q

When is GLP-1 receptor agonist prescribed?

A

Add-on if triple therapy ineffective.

72
Q

ADRs of GLP-1 receptor agonists.

A

GI upset

GORD

73
Q

Contraindications of GLP-1 receptor agonists.

A

Stop if eGFR <30 ml/min

Other hypoglycaemic agents

74
Q

Why is modified release commonly used in diabetes treatment?

A

Less GI upset, less frequent dosing and a slower release.

75
Q

Why are tablets swallowed whole?

A

So it isn’t released and absorbed to quickly

76
Q

What is diabulimia?

A

Diabetes eating disorder

77
Q

Why caution of metformin in impaired renal function?

A

Can lead to lactic acidosis because of build up of lactate due to inhibition of gluconeogenesis and therefore the cori cycle.

Normally the kidneys can deal with this but if impaired it can lead to build up and lactic acidosis.

78
Q

Why do sulfonylureas tend to promote weight gain?

A

Stimulate secretion of insulin and weight gain through the anabolic effects of insulin.

79
Q

How is insuline release controlled at site of injection?

A

It’s in soluble form. This means that it forms hexamers in order to not get absorbed all at once.